[1]
D. P. Safnurbaiti, T. M. Andayani, and F. Irijanto, “Cost Analysis and Value of Utility for Patients in Haemodialysis with Carbonic Cevelamer Therapy”, Biomed Journal, vol. 1, no. 2, pp. 79–89, Jul. 2018.